Sample | Title | Value | Rank |
GSM1116933 | Synovial tissue prior to Tocilizumab therapy, repl 1 | -0.749272 | 1 |
GSM1116935 | Synovial tissue prior to Tocilizumab therapy, repl 2 | 2.85166 | 99 |
GSM1116937 | Synovial tissue prior to Tocilizumab therapy, repl 3 | 4.27857 | 100 |
GSM1116939 | Synovial tissue prior to Tocilizumab therapy, repl 4 | -1.41736 | 1 |
GSM1116941 | Synovial tissue prior to Tocilizumab therapy, repl 5 | -1.59259 | 1 |
GSM1116943 | Synovial tissue prior to Tocilizumab therapy, repl 6 | 2.10394 | 99 |
GSM1116945 | Synovial tissue prior to Tocilizumab therapy, repl 7 | 5.24213 | 100 |
GSM1116947 | Synovial tissue prior to Tocilizumab therapy, repl 8 | 0.420783 | 94 |
GSM1116949 | Synovial tissue prior to Tocilizumab therapy, repl 9 | 0.0572701 | 68 |
GSM1116951 | Synovial tissue prior to Tocilizumab therapy, repl 10 | -0.548537 | 2 |
GSM1116953 | Synovial tissue prior to Tocilizumab therapy, repl 11 | 2.11986 | 99 |
GSM1116955 | Synovial tissue prior to Tocilizumab therapy, repl 12 | 1.55368 | 99 |
GSM1116934 | Synovial tissue after to Tocilizumab therapy, repl 1 | -1.22274 | 2 |
GSM1116936 | Synovial tissue after to Tocilizumab therapy, repl 2 | -0.0572701 | 35 |
GSM1116938 | Synovial tissue after to Tocilizumab therapy, repl 3 | 2.06124 | 99 |
GSM1116940 | Synovial tissue after to Tocilizumab therapy, repl 4 | 0.736767 | 96 |
GSM1116942 | Synovial tissue after to Tocilizumab therapy, repl 5 | 1.2693 | 99 |
GSM1116944 | Synovial tissue after to Tocilizumab therapy, repl 6 | 3.7294 | 100 |
GSM1116946 | Synovial tissue after to Tocilizumab therapy, repl 7 | 5.17855 | 100 |
GSM1116948 | Synovial tissue after to Tocilizumab therapy, repl 8 | -0.545805 | 3 |
GSM1116950 | Synovial tissue after to Tocilizumab therapy, repl 9 | -0.622647 | 2 |
GSM1116952 | Synovial tissue after to Tocilizumab therapy, repl 10 | -0.5577 | 1 |
GSM1116954 | Synovial tissue after to Tocilizumab therapy, repl 11 | 0.0769405 | 68 |
GSM1116956 | Synovial tissue after to Tocilizumab therapy, repl 12 | -1.77963 | 1 |